http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110201193-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110201193-B |
titleOfInvention | Method for preparing bimodal imaging nano composite by spontaneous reduction of potassium permanganate through molybdenum disulfide quantum dots |
abstract | The invention discloses a method for preparing a bimodal imaging nano composite by spontaneous reduction of potassium permanganate by molybdenum disulfide quantum dots, comprising the following steps of a, adding a potassium permanganate solution into a molybdenum disulfide quantum dot solution, uniformly mixing, and reacting for 24 hours in an environment at 4 ℃; b. b, ultrafiltering the solution after the reaction in the step a to remove unreacted raw materials to obtain MnO 2 /MoS 2 A nanocomposite. The invention uses MoS 2 MnO is prepared in one step by using QDs as reducing agent and through spontaneous reduction of potassium permanganate 2 /MoS 2 QDs fluorescence/magnetic resonance bimodal imaging nano-composite and preparation of MnO by existing oxidation method 2 Compared with the prior art, the preparation method is simple and easy to operate, and a self-sacrifice template or a chelating agent is not required to be introduced; compared with the prior reduction preparation method, the prepared MnO 2 /MoS 2 The nano-composite not only has MRI signals responded by a tumor microenvironment, but also has fluorescence imaging signals responded by the tumor microenvironment, simplifies the preparation process of the multi-modal nano-composite, and has relatively loose requirements on preparation conditions. |
priorityDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.